Reinventing respiration monitoring
Company is active
Event Year: 2021
Company is active
Event Year: 2021
Makani Science, headquartered in Irvine, California, is innovating respiratory monitoring through its development of a wireless patch designed for accurate and continuous breath analysis. Founded by Dr. Michelle Khine and Dr. Michael Chu, experts in wearable monitoring from the University of California, Irvine, the company aims to transform respiratory care.
The Makani Science system captures unique breathing waveforms from patients in real-world settings, establishing a comprehensive database of respiratory patterns linked to various diseases. Initially, this data will be gathered via systems deployed in a focused beachhead market, enhancing monitoring safety for patients undergoing sedation during medical procedures. The company's long-term vision involves leveraging machine learning in conjunction with this extensive database to identify and predict respiratory complications across diverse patient populations.
With a highly experienced team, Makani Science anticipates FDA clearance within a year for its initial target market, paving the way for broader applications of its respiratory monitoring technology.
Makani Science, headquartered in Irvine, California, is innovating respiratory monitoring through its development of a wireless patch designed for accurate and continuous breath analysis. Founded by Dr. Michelle Khine and Dr. Michael Chu, experts in wearable monitoring from the University of California, Irvine, the company aims to transform respiratory care.
The Makani Science system captures unique breathing waveforms from patients in real-world settings, establishing a comprehensive database of respiratory patterns linked to various diseases. Initially, this data will be gathered via systems deployed in a focused beachhead market, enhancing monitoring safety for patients undergoing sedation during medical procedures. The company's long-term vision involves leveraging machine learning in conjunction with this extensive database to identify and predict respiratory complications across diverse patient populations.
With a highly experienced team, Makani Science anticipates FDA clearance within a year for its initial target market, paving the way for broader applications of its respiratory monitoring technology.
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2021
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2021
Healthcare
Healthcare
Healthcare -> Medical Devices
Healthcare -> Medical Devices
Team size: 2
Hiring: No
Team size: 2
Hiring: No